financetom
Business
financetom
/
Business
/
Travel + Leisure Q2 Adjusted Earnings, Net Revenue Rise; Offers Q3, Full Year Adjusted EBITDA Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Travel + Leisure Q2 Adjusted Earnings, Net Revenue Rise; Offers Q3, Full Year Adjusted EBITDA Guidance
Jul 24, 2024 4:34 AM

07:02 AM EDT, 07/24/2024 (MT Newswires) -- Travel + Leisure ( TNL ) reported Q2 adjusted earnings Wednesday of $1.52 per diluted share, up from $1.33 a year earlier.

Analysts polled by Capital IQ expected $1.41.

Net revenue for the quarter ended on June 30 was $985 million, up from $949 million a year earlier.

Analysts surveyed by Capital IQ expected $987.2 million.

The company expects Q3 adjusted EBITDA of $235 million to $245 million. Analysts polled by Capital IQ expect $238.7 million. The company updated its full-year adjusted EBITDA to a new range of $915 million to $935 million versus the prior outlook of $910 million to $930 million. Analysts polled by Capital IQ expect $921.6 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UnitedHealth's Change to start processing $14 billion in medical claims as services come online
UnitedHealth's Change to start processing $14 billion in medical claims as services come online
Mar 22, 2024
(Reuters) -UnitedHealth Group ( UNH ) said on Friday it expects more than $14 billion in medical claims to start flowing soon through its unit Change Healthcare as several services for handling them gradually come online over the next few weeks following a hack last month. The health insurer said its software for preparing medical claims Assurance went online on...
Invivyd's Covid Treatment for Immunodeficiency Disorders Gets FDA Nod; Shares Up Before Trading Halt
Invivyd's Covid Treatment for Immunodeficiency Disorders Gets FDA Nod; Shares Up Before Trading Halt
Mar 22, 2024
03:57 PM EDT, 03/22/2024 (MT Newswires) -- Invivyd ( IVVD ) stock was up 4.5% Friday before its trading was halted to announce an emergency use authorization for its Pemgarda monoclonal antibody to prevent COVID-19 in adults and youths with moderate-to-severe immunodeficiency disorders. The US Food and Drug Administration decision makes Pemgarda available to people 12 years or older with...
Anthropic weighs slate of sovereign wealth funds to acquire FTX's $1 bln stake, CNBC reports
Anthropic weighs slate of sovereign wealth funds to acquire FTX's $1 bln stake, CNBC reports
Mar 22, 2024
March 22 (Reuters) - Anthropic, backed by Google and Amazon.com ( AMZN ), is weighing a slate of sovereign wealth funds to acquire FTX's stake of about $1 billion in the AI startup, CNBC reported on Friday citing sources. In February, a U.S. judge ruled that bankrupt crypto exchange FTX may sell its shares in Anthropic. FTX invested $500 million...
Update: Market Chatter: Ares Management, KKR Looking to Take Over Barings' Investments Following Exodus
Update: Market Chatter: Ares Management, KKR Looking to Take Over Barings' Investments Following Exodus
Mar 22, 2024
03:56 PM EDT, 03/22/2024 (MT Newswires) -- (Updates with Ares and KKR declining to comment in fifth paragraph.) Ares Management ( ARES ) , KKR (KKR) and other private credit firms are keen to take advantage of troubles at Barings after more than 20 of its senior executives moved to Corinthia Global Management earlier this month, Bloomberg reported Friday. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved